Marie-Louise VachonM.D., M.Sc., FRCP(C)

Marathe G, Moodie EEM, Brouillette MJ, Lanièce Delaunay C, Cox J, Martel-Laferrière V, Gill J, Cooper C, Pick N, Vachon ML, Vachon ML, Walmsley S, Klein MB,

Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada

Clin Infect Dis, 76 (3), 2023.

Résumé | Liens:

Marathe G, Moodie EEM, Brouillette MJ, Cox J, Cooper C, Delaunay CL, Conway B, Hull M, Martel-Laferrière V, Vachon ML, Walmsley S, Wong A, Klein MB,

Predicting the presence of depressive symptoms in the HIV-HCV co-infected population in Canada using supervised machine learning

BMC Med Res Methodol, 22 (1), 2022.

Résumé | Liens:

Pedersen J, Moukandja IP, Ndidi S, Sørensen AL, Koumakpayi IH, Lekana-Douki JB, Vachon ML, Weis N, Kobinger G, Fausther-Bovendo H

An adaptable platform for in-house hepatitis C serology

J Virol Methods, 308 , 2022.

Résumé | Liens:

Driedger M, Vachon ML, Wong A, Conway B, Ramji A, Borgia S, Tam E, Barrett L, Smyth D, Feld JJ, Lee SS, Cooper C

Direct-acting antiviral treatment uptake and sustained virological response outcomes are not affected by alcohol use: A CANUHC analysis

Can Liver J, 4 (3), 2021.

Résumé | Liens:

Onofrio FQ, Cooper C, Borgia SM, Vachon ML, Ramji A, Lilly LB, Wong A, Booth J, Sattar I, Morales H, Lee S, Conway B, Feld JJ

Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian Registry

Clin Infect Dis, 72 (11), 2021.

Résumé | Liens:

Manion M, Lynn N, Pei L, Hammoud DA, Laidlaw E, Roby G, Metzger D, Mejia Y, Lisco A, Zelazny A, Holland S, Vachon ML, Scherer M, Bergin C, Sereti I

To Induce Immune Reconstitution Inflammatory Syndrome or Suppress It: The Spectrum of Mycobacterium genavense in the Antiretroviral Era

Clin Infect Dis, 72 (2), 2021.

Résumé | Liens:

Cooper CL, Read D, Vachon ML, Conway B, Wong A, Ramji A, Borgia S, Tam E, Barrett L, Smyth D, Feld JJ, Lee S,

Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants

BMC Public Health, 20 (1), 2020.

Résumé | Liens:

Saeed S, Strumpf E, Moodie EEM, Wong L, Cox J, Walmsley S, Tyndall M, Cooper C, Conway B, Hull M, Martel-Laferriere V, Gill J, Wong A, Vachon ML, Klein MB,

Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus

Clin Infect Dis, 71 (2), 2020.

Résumé | Liens:

Tam E, Borgia S, Yoshida EM, Cooper C, Ford JA, Vachon ML, Sherman M, Halsey-Brandt J

Real-world health care utilization in treatment of HCV: Results from the Canadian SIMPLE observational trial

Can Liver J, 2 (3), 2019.

Résumé | Liens:

Murphy DG, Dion R, Simard M, Vachon ML, Martel-Laferrière V, Serhir B, Longtin J

Molecular surveillance of hepatitis C virus genotypes identifies the emergence of a genotype 4d lineage among men in Quebec, 2001-2017

Can Commun Dis Rep, 45 (9), 2019.

Résumé | Liens: